US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...
Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review ...
Ahead of the opening bell, the drugmaker said it plans to sell about 13.2 million shares of common stock at $1.90 apiece. Inovio will also grant underwriters a 30-day option to purchase up to nearly 2 ...
InvestorsHub on MSN
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering
INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% in early trading after the biotech company announced the pricing of ...
Investing.com -- INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% after the biotechnology company announced the pricing of an underwritten public offering at $1.90 per share, representing a ...
TipRanks on MSN
Inovio 13.16M share Spot Secondary priced at $1.90
Pharmaceuticals announced the pricing of an underwritten public offering of 13,158,000 shares of its common stock at a public ...
Inovio Pharmaceuticals Inc (INO) showcases significant progress in its BLA submission for INO-3107, while navigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback